PDF file - Via Medica Journals
... rehospitalizations. All these variables have been associated with worse outcome in previous publications. The novel information provided by this study is the integration of predictors of adverse outcomes with troponin levels. As expected, the use of inotropic agents was a stronger predictor of event ...
... rehospitalizations. All these variables have been associated with worse outcome in previous publications. The novel information provided by this study is the integration of predictors of adverse outcomes with troponin levels. As expected, the use of inotropic agents was a stronger predictor of event ...
View PDF - Sanofi
... HCM Patient Subgroup with LVOT Obstruction In our Phase 1 single dose study, two HCM patients, both with a history of LVOT obstruction, had provocable gradients before administration of a single 96 mg dose of MYK-461 (28 mmHg and 42 mmHg, respectively). In both patients, their gradients were reduced ...
... HCM Patient Subgroup with LVOT Obstruction In our Phase 1 single dose study, two HCM patients, both with a history of LVOT obstruction, had provocable gradients before administration of a single 96 mg dose of MYK-461 (28 mmHg and 42 mmHg, respectively). In both patients, their gradients were reduced ...
- International Cardiovascular Forum Journal
... evaluate the QoL in HF patients in Kosovo. Methods: The study subjects were 103 consecutive HF patients (63±10 years, 56 female, 48% hypertensive and 26% ischaemic etiology, classified as NYHA I-III) admitted in outpatient or in-patient clinics at University Clinical Centre of Kosovo. At the moment ...
... evaluate the QoL in HF patients in Kosovo. Methods: The study subjects were 103 consecutive HF patients (63±10 years, 56 female, 48% hypertensive and 26% ischaemic etiology, classified as NYHA I-III) admitted in outpatient or in-patient clinics at University Clinical Centre of Kosovo. At the moment ...
Measure Information Form
... without both angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) contraindications who are prescribed an ACEI or ARB at hospital discharge. For purposes of this measure, LVSD is defined as chart documentation of a left ventricular ejection fraction (LVEF) less than ...
... without both angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) contraindications who are prescribed an ACEI or ARB at hospital discharge. For purposes of this measure, LVSD is defined as chart documentation of a left ventricular ejection fraction (LVEF) less than ...
Anti-remodelling Therapy (cont…)
... blunts autonomic remodelling and prevents AF-inducibility in animal models. ...
... blunts autonomic remodelling and prevents AF-inducibility in animal models. ...
Acute Myocardial Infarction/Complications
... presence and extent of inducible ischemia in patients who have not had coronary angiography and do not have high-risk clinical features for which coronary angiography would be warranted (LOE: B). Echocardiography is reasonable to clarify the diagnosis of STEMI and allow risk stratification of patien ...
... presence and extent of inducible ischemia in patients who have not had coronary angiography and do not have high-risk clinical features for which coronary angiography would be warranted (LOE: B). Echocardiography is reasonable to clarify the diagnosis of STEMI and allow risk stratification of patien ...
united states securities and exchange commission - corporate
... combined with any of the current standard-of-care drugs for heart attack patients. It is conveniently administered by an interventional cardiologist as a one-time, 30-to-60 second injection of BCM solution using a procedure routinely performed by interventional cardiologists. A recently published o ...
... combined with any of the current standard-of-care drugs for heart attack patients. It is conveniently administered by an interventional cardiologist as a one-time, 30-to-60 second injection of BCM solution using a procedure routinely performed by interventional cardiologists. A recently published o ...
Secondary Prevention of Coronary Artery Disease
... in microvascular complications, including nephropathy, but increased adverse effects were observed, including weight gain, fluid retention, and symptomatic hypoglycemia.28-31 The largest recent trial investigating cardiovascular outcomes with intensive glucose control was discontinued early Clinical ...
... in microvascular complications, including nephropathy, but increased adverse effects were observed, including weight gain, fluid retention, and symptomatic hypoglycemia.28-31 The largest recent trial investigating cardiovascular outcomes with intensive glucose control was discontinued early Clinical ...
- Wiley Online Library
... those receiving propofol, P = 0.002. The 1-year follow-up identified two patients who died in the propofol group (one myocardial infarction and one low cardiac output syndrome) and one in the sevoflurane group (myocardial infarction). Conclusion: In this study, patients with coronary artery disease ...
... those receiving propofol, P = 0.002. The 1-year follow-up identified two patients who died in the propofol group (one myocardial infarction and one low cardiac output syndrome) and one in the sevoflurane group (myocardial infarction). Conclusion: In this study, patients with coronary artery disease ...
heart health
... in the West, a deadly and disabling condition. A huge problem in the UK and the United States. Too little exercise, has been directly associated with heart failure. Around ten percent of Heart Failure patients die every year. ...
... in the West, a deadly and disabling condition. A huge problem in the UK and the United States. Too little exercise, has been directly associated with heart failure. Around ten percent of Heart Failure patients die every year. ...
Clinical implications of QT internal measurements
... bears increased risk for death, while frequent ectopy during X does not (NEJM 2003;348:781). One possible explanation for arrhythmia facilitation during R is increased dispersion of the repolarization (DOR). We compared DOR indexes in the X-ECGs and R-ECGs obtained during a maximal exercise test to ...
... bears increased risk for death, while frequent ectopy during X does not (NEJM 2003;348:781). One possible explanation for arrhythmia facilitation during R is increased dispersion of the repolarization (DOR). We compared DOR indexes in the X-ECGs and R-ECGs obtained during a maximal exercise test to ...
Long-Term Disease Management of Patients With Coronary
... 2000. All had suffered an acute-cardiac event including acute myocardial infarction, coronary bypass surgery, and/or percutaneous coronary revascularization. The only exclusion criterion was unavailability for long-term disease management. Of the 605 patients who started outpatient CR in 1999 and 20 ...
... 2000. All had suffered an acute-cardiac event including acute myocardial infarction, coronary bypass surgery, and/or percutaneous coronary revascularization. The only exclusion criterion was unavailability for long-term disease management. Of the 605 patients who started outpatient CR in 1999 and 20 ...
PHYSICAL FITNESS AND CARDIOVASCULAR ENDURANCE
... • Cardio - the heart – about the size of a fist • The Heart – a hollow organ containing 4 chambers • Septum – wall which divides the heart cavity into a “right heart” & a “left heart” • Right Atrium/Left Atrium – holding tanks for the blood ...
... • Cardio - the heart – about the size of a fist • The Heart – a hollow organ containing 4 chambers • Septum – wall which divides the heart cavity into a “right heart” & a “left heart” • Right Atrium/Left Atrium – holding tanks for the blood ...
Galaxy CRT-D Brochure
... pharmacologic therapy (OPT) for heart failure and who meet any one of the following classifications: Moderate to severe heart failure (NYHA Class III-IV) with EF ≤ 35% and QRS duration ≥ 120 ms; or left bundle branch block (LBBB) with QRS duration ≥ 130 ms, EF ≤ 30%, and mild (NYHA Class II) ischemi ...
... pharmacologic therapy (OPT) for heart failure and who meet any one of the following classifications: Moderate to severe heart failure (NYHA Class III-IV) with EF ≤ 35% and QRS duration ≥ 120 ms; or left bundle branch block (LBBB) with QRS duration ≥ 130 ms, EF ≤ 30%, and mild (NYHA Class II) ischemi ...
File
... • Spironolactone is a direct antagonist of aldosterone, thereby preventing salt retention, myocardial hypertrophy, and hypokalemia. • Eplerenone is a competitive antagonist of aldosterone at mineralocorticoid receptors. • Although similar in action to spironolactone at the mineralocorticoid receptor ...
... • Spironolactone is a direct antagonist of aldosterone, thereby preventing salt retention, myocardial hypertrophy, and hypokalemia. • Eplerenone is a competitive antagonist of aldosterone at mineralocorticoid receptors. • Although similar in action to spironolactone at the mineralocorticoid receptor ...
resynchronisation therapy in adults with congenital heart disease
... Objectives:Cardiac resynchronization therapy (CRT) may be of particular benefit to adults with congenital heart disease (CHD) and ventricular dysfunction (VD). Methods : Retrospective hospital records review.Results:Between 2001 & 2004, 6 patients (pt) had 5 successful implants, 4 with defibrillator ...
... Objectives:Cardiac resynchronization therapy (CRT) may be of particular benefit to adults with congenital heart disease (CHD) and ventricular dysfunction (VD). Methods : Retrospective hospital records review.Results:Between 2001 & 2004, 6 patients (pt) had 5 successful implants, 4 with defibrillator ...
Angiotensin-Converting Enzyme Inhibitors in Patients
... cardiovascular disease. Risk in these latter populations was similar to that in patients with documented CAD in the corresponding trials; in addition, in HOPE, the effect of ACE inhibitor therapy was also highly significant when the analysis was restricted to the subset of patients with documented C ...
... cardiovascular disease. Risk in these latter populations was similar to that in patients with documented CAD in the corresponding trials; in addition, in HOPE, the effect of ACE inhibitor therapy was also highly significant when the analysis was restricted to the subset of patients with documented C ...
Treatment of heart failure with preserved Karen Hogg, John J.V. McMurray*
... exercise, but in the elderly and hypertensive subjects this physiological response is exaggerated 27–30 ; and it is thought that this may be partially mediated by angiotensin II, the circulating levels of which increase during exercise 31 . In one small, randomised, placebocontrolled, double-blind, ...
... exercise, but in the elderly and hypertensive subjects this physiological response is exaggerated 27–30 ; and it is thought that this may be partially mediated by angiotensin II, the circulating levels of which increase during exercise 31 . In one small, randomised, placebocontrolled, double-blind, ...
Case Study 1- Unit 8
... You discuss with Mr. H the damage to his heart. You want to impress upon him the other end organ damage that occurs with untreated hypertension. What Clinical Signs and symptoms might there be? Now that Mr. H is aware of the potential harms of end organ damage that may occur with untreated hypertens ...
... You discuss with Mr. H the damage to his heart. You want to impress upon him the other end organ damage that occurs with untreated hypertension. What Clinical Signs and symptoms might there be? Now that Mr. H is aware of the potential harms of end organ damage that may occur with untreated hypertens ...
Neurologists, Cardiologists and GPs working together
... asasantin (10 changed from aspirin to asasantin and 4 de novo asasantin), 14 patients on aspirin monotherapy (including 9 de novo patients), 6 patients on aspirin/clopidogrel (vs 1 pre-clinic), 5 patients on clopidogrel monotherapy, 4 patients on warfarin. ...
... asasantin (10 changed from aspirin to asasantin and 4 de novo asasantin), 14 patients on aspirin monotherapy (including 9 de novo patients), 6 patients on aspirin/clopidogrel (vs 1 pre-clinic), 5 patients on clopidogrel monotherapy, 4 patients on warfarin. ...
Initial Clinical Experience with the HeartMate® II Axial
... devices are smaller and simpler than pulsatile pumps.1-4 Having only 1 moving component, no valves, and no vent or compliance chamber greatly reduces the complexity of these pumps and should lead to better reliability than that shown by the widely used implantable pulsatile pumps. Because of their s ...
... devices are smaller and simpler than pulsatile pumps.1-4 Having only 1 moving component, no valves, and no vent or compliance chamber greatly reduces the complexity of these pumps and should lead to better reliability than that shown by the widely used implantable pulsatile pumps. Because of their s ...
Arterial blood gases during treatment of congestive heart failure
... anesthetized dogs, it has bean shown that the decreased oxygen tension that develops in these animals cannot be ...
... anesthetized dogs, it has bean shown that the decreased oxygen tension that develops in these animals cannot be ...
Gallop through CHF
... not they have experienced an MI – Stable Stage C and D patients. They should have no or minimal evidence of fluid retention and have not recently required positive ...
... not they have experienced an MI – Stable Stage C and D patients. They should have no or minimal evidence of fluid retention and have not recently required positive ...
and in Diastolic and Systolic Heart Failure
... not they have experienced an MI – Stable Stage C and D patients. They should have no or minimal evidence of fluid retention and have not recently required positive ...
... not they have experienced an MI – Stable Stage C and D patients. They should have no or minimal evidence of fluid retention and have not recently required positive ...